Dipna Pharmachem Approves Secretarial Auditor FY 2025-26

1 min read     Updated on 25 May 2026, 04:27 PM
scanx
Reviewed by
Shriram SScanX News Team
AI Summary

Dipna Pharmachem Limited has successfully concluded its postal ballot process for the appointment of M/s. Jay Pandya & Associates as Secretarial Auditor for the financial year 2025-26. The resolution received strong shareholder approval, with 99.77% of valid votes cast in favour. The e-voting process was conducted from April 23, 2026, to May 22, 2026, in compliance with SEBI regulations.

powered bylight_fuzz_icon
41252141

*this image is generated using AI for illustrative purposes only.

Dipna Pharmachem Limited has announced the outcome of its postal ballot process for the appointment of a secretarial auditor for the financial year 2025-26. The company sought shareholder approval for the appointment of M/s. Jay Pandya & Associates, Company Secretaries, Ahmedabad, through an ordinary resolution. The remote e-voting period concluded on May 22, 2026.

The resolution was approved with the requisite majority by the shareholders. The scrutinizer's report confirmed the outcome, detailing the votes cast in favour and against the proposal. The appointment is effective for the specified financial year.

Voting Results

The postal ballot results indicate strong shareholder support for the resolution. A total of 2,652,450 valid votes were cast, with the majority favouring the appointment.

Resolution No. Votes in favour % of Valid Votes Votes against % of Valid Votes Invalid Votes
01 2,646,450 99.77 6,000 0.23 0

Process Details

The remote e-voting process was conducted in compliance with the provisions of Section 108 and 110 of the Companies Act, 2013, and relevant SEBI regulations. The e-voting period was open from April 23, 2026, to May 22, 2026. The cut-off date for determining shareholder eligibility was April 17, 2026. M/s. Jay Pandya & Associates acted as the scrutinizer for the process.

Historical Stock Returns for Dipna Pharmachem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-6.80%-11.96%-58.32%-68.57%-74.53%

How might M/s. Jay Pandya & Associates' secretarial audit findings for FY 2025-26 impact Dipna Pharmachem's corporate governance ratings and investor confidence?

What potential compliance gaps or regulatory risks could the new secretarial auditor uncover given the pharmaceutical sector's evolving regulatory landscape?

Will the 0.23% dissenting shareholder votes signal any underlying concerns about Dipna Pharmachem's governance practices that could influence future resolutions?

Dipna Pharmachem Postal Ballot for Secretarial Auditor Appointment FY 2025-26

2 min read     Updated on 22 Apr 2026, 05:13 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Dipna Pharmachem Limited announced a postal ballot notice for appointing M/s. Jay Pandya & Associates as Secretarial Auditor for FY 2025-26, following board approval on April 22, 2026. The appointment requires shareholder approval through remote e-voting from April 23 to May 22, 2026, with results to be announced by May 26, 2026. The firm holds FRN S2024GJ963300 and Peer Review Certificate No. 7830/2026.

powered bylight_fuzz_icon
38402658

*this image is generated using AI for illustrative purposes only.

Dipna Pharmachem Limited has announced a postal ballot notice for the appointment of M/s. Jay Pandya & Associates as Secretarial Auditor for the financial year 2025-26. The appointment, approved by the Board of Directors on April 22, 2026, is subject to shareholder approval through remote e-voting only, in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Board Meeting and Appointment Details

The board meeting was held on April 22, 2026, at the company's registered office in Ahmedabad. The appointment of M/s. Jay Pandya & Associates was recommended by the Audit Committee and approved by the board in compliance with Regulation 24A of SEBI LODR Regulations and Section 204 of the Companies Act, 2013.

Parameter Details
Meeting Date April 22, 2026
Venue A/211, Siddhi Vinayak Complex, Near D.A.V. School, Makarba, Ahmedabad
Auditor Firm M/s. Jay Pandya & Associates
FRN Number S2024GJ963300
Peer Review Certificate No. 7830/2026
Membership No. ACS – 63213
COP No. 24319
Security Code 543594
CIN L24100GJ2011PLC066400

Shareholder Approval Through Remote E-Voting

The appointment requires shareholder approval through a postal ballot process using remote e-voting only. The company has engaged National Securities Depository Limited (NSDL) to facilitate the electronic voting process. The postal ballot notice is being sent electronically to members whose email addresses are registered with the Registrar and Share Transfer Agent (M/s. Bigshare Services Private Limited) and the depositories (NSDL and CDSL) as on the cut-off date of April 17, 2026.

Process Details Timeline
Voting Method Remote e-voting only
Cut-off Date April 17, 2026
Commencement April 23, 2026 at 9:00 AM IST
Conclusion May 22, 2026 at 5:00 PM IST
Result Announcement By May 26, 2026

Auditor Profile and Credentials

M/s. Jay Pandya & Associates is a practicing Company Secretaries firm with extensive experience in corporate law and securities regulations. The firm is peer-reviewed and eligible for appointment as Secretarial Auditors, with no disqualifications under SEBI Listing Regulations as per the SEBI Circular dated December 31, 2024. Mr. Jay Pandya, Proprietor of the firm, has been appointed as the Scrutinizer to conduct the postal ballot process in a fair and transparent manner.

The company confirmed that there are no relationships between the auditor firm and the company's directors, ensuring independence in the audit process. The Board and Audit Committee evaluated the firm's credentials, expertise, professional standing, and technical competence before recommending the appointment.

Regulatory Compliance and Filing

The company has filed the necessary documentation with BSE Limited under Regulation 30. The appointment is made to comply with the Companies Act, 2013 and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 requirements. The resolution, if approved by the requisite majority of members, shall be deemed to have been passed on May 22, 2026, being the last date specified for e-voting.

Compliance Details Information
Managing Director Keyur Dipakkumar Shah (DIN: 03167258)
Resolution Type Ordinary Resolution
RTA M/s. Bigshare Services Private Limited
E-Voting Service Provider NSDL

Historical Stock Returns for Dipna Pharmachem

1 Day5 Days1 Month6 Months1 Year5 Years
0.0%-6.80%-11.96%-58.32%-68.57%-74.53%

What factors might influence shareholder voting patterns on this secretarial auditor appointment, and what approval threshold is typically expected?

How might the new secretarial auditor's expertise in M&A and listing services signal potential strategic initiatives for Dipna Pharmachem in FY 2025-26?

What regulatory changes or compliance challenges in the pharmaceutical sector could drive the need for specialized secretarial audit services?

More News on Dipna Pharmachem

1 Year Returns:-68.57%